4.1 Review

Multiplicity of mammalian Reductases for xenobiotic carbonyl compounds

期刊

DRUG METABOLISM AND PHARMACOKINETICS
卷 21, 期 1, 页码 1-18

出版社

JAPANESE SOC STUDY XENOBIOTICS
DOI: 10.2133/dmpk.21.1

关键词

carbonyl reduction; short-chain dehydrogenase/reductase superfamily; aldo-keto reductase superfamily; carbonyl reductase; hydroxysteroid dehydrogenase; species difference

向作者/读者索取更多资源

A variety of carbonyl compounds are present in foods, environmental pollutants, and drugs. These xenobiotic carbonyl compounds are metabolized into the corresponding alcohols by many mammalian NAD(P)H-dependent reductases, which belong to the short-chain dehydrogenase/reductase (SDR) and aldo-keto reductase superfamilies. Recent genomic analysis, cDNA isolation and characterization of the recombinant enzymes suggested that, in humans, the six members of each of the two superfamilies, i.e., total of 12 enzymes, are involved in the reductive metabolism of xenobiotic carbonyl compounds. They comprise three types of carbonyl reductase, dehydrogenase/reductase (SDR family) member 4, 11 beta-hydroxysteroid dehydrogenase type 1, L-xylulose reductase, two types of aflatoxin B-1 aldehyde reductase, 20 alpha-hydroxysteroid dehydrogenase, and three types of 3 alpha-hydroxysteroid dehydrogenase. Accumulating data on the human enzymes provide new insights into their roles in cellular and molecular reactions including xenobiotic metabolism. On the other hand, mice and rats lack the gene for a protein corresponding to human 3 alpha-hydroxysteroid dehydrogenase type 3, but instead possess additional five or six genes encoding proteins that are structurally related to human hydroxysteroid dehydrogenases. Characterization of the additional enzymes suggested their involvement in species-specific biological events and species differences in the metabolism of xenobiotic carbonyl compounds.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据